Benovic J L, Kühn H, Weyand I, Codina J, Caron M G, Lefkowitz R J
Department of Medicine (Cardiology), Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710.
Proc Natl Acad Sci U S A. 1987 Dec;84(24):8879-82. doi: 10.1073/pnas.84.24.8879.
The beta-adrenergic receptor kinase is an enzyme, possibly analogous to rhodopsin kinase, that multiply phosphorylates the beta-adrenergic receptor only when it is occupied by stimulatory agonists. Since this kinase may play an important role in mediating the process of homologous, or agonist-specific, desensitization, we investigated the functional consequences of receptor phosphorylation by the kinase and possible analogies with the mechanism of action of rhodopsin kinase. Pure hamster lung beta 2-adrenergic receptor, reconstituted in phospholipid vesicles, was assessed for its ability to mediate agonist-promoted stimulation of the GTPase activity of coreconstituted stimulatory guanine nucleotide-binding regulatory protein. When the receptor was phosphorylated by partially (approximately 350-fold) purified preparations of beta-adrenergic receptor kinase, as much as 80% inactivation of its functional activity was observed. However, the use of more highly purified enzyme preparations led to a dramatic decrease in the ability of phosphorylation to inactivate the receptor such that pure enzyme preparations (approximately 20,000-fold purified) caused only minimal (approximately 1off/- 7%) inactivation. Addition of pure retinal arrestin (48-kDa protein or S antigen), which is involved in enhancing the inactivating effect of rhodopsin phosphorylation by rhodopsin kinase, led to partial restoration of the functional effect of beta-adrenergic receptor kinase-promoted phosphorylation (41 +/- 3% inactivation). These results suggest the possibility that a protein analogous to retinal arrestin may exist in other tissues and function in concert with beta-adrenergic receptor kinase to regulate the activity of adenylate cyclase-coupled receptors.
β - 肾上腺素能受体激酶是一种酶,可能类似于视紫红质激酶,仅在被刺激性激动剂占据时才会对β - 肾上腺素能受体进行多次磷酸化。由于这种激酶可能在介导同源或激动剂特异性脱敏过程中起重要作用,我们研究了该激酶对受体磷酸化的功能后果以及与视紫红质激酶作用机制可能的相似之处。对重构于磷脂囊泡中的纯仓鼠肺β₂ - 肾上腺素能受体进行评估,以检测其介导激动剂促进共重构的刺激性鸟嘌呤核苷酸结合调节蛋白GTP酶活性的能力。当受体被部分纯化(约350倍)的β - 肾上腺素能受体激酶制剂磷酸化时,观察到其功能活性有高达80%的失活。然而,使用纯度更高的酶制剂会导致磷酸化使受体失活的能力显著下降,以至于纯酶制剂(约20000倍纯化)仅引起最小程度(约10% - 7%)的失活。添加纯视网膜抑制蛋白(48 kDa蛋白或S抗原),其参与增强视紫红质激酶对视紫红质磷酸化的失活作用,导致β - 肾上腺素能受体激酶促进的磷酸化功能效应部分恢复(41 ± 3%失活)。这些结果提示,在其他组织中可能存在一种类似于视网膜抑制蛋白的蛋白质,它与β - 肾上腺素能受体激酶协同作用以调节腺苷酸环化酶偶联受体的活性。